Founded in 2010, Orbicular Pharmaceutical Technologies operates in Health Tech offering specialty pharmaceutical solutions through the development of niche and complex dosage forms for licensing to gl...
Funding stage:
Undisclosed
Last funding:
30/05/2024
Total funding:
$20.00 Mn+
Revenue:
Investors
Employee count:
256
Last 90d
256
Last 90d
Web traffic:
1.42K
1.42K
Last 30d
Last 30d
Glassdoor Rating:
Orbicular Pharmaceutical Technologies: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders7
Latest Filing Date30 May 2024- Funding Events23
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Orbicular Pharmaceutical Technologies
As of 31 May 2024, Orbicular Pharmaceutical Technologies's equity is held by 7 shareholders, with the top three being M S Mohan, Hiren Patel, and Meena Mohan.
M S Mohan holds the largest stake in Orbicular Pharmaceutical Technologies at 47.0% as of 31 May 2024.
As of 31 May 2024, founders collectively hold 79.2% equity in Orbicular Pharmaceutical Technologies.
As of 31 May 2024, investors collectively hold 10.7% equity in Orbicular Pharmaceutical Technologies.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links